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HORMONAL EFFECTS ON MTJCOPOLYSACCHARIDE SYNTHE-
SIZING ENZYMES IN DMBA-TREATED MOUSE SKIN*
SOICHIRO SASAKI, M.D.
In recent years the alterations in the der-
mal ground substance AMPS' and the corre-
lation with careinogenesis have been studied
(1, 2). It is now considered that the ground
substance AMPS are indispensable to the neo-
plastic process, possibly because they provide
a suitable matrix for the proliferating epi-
dermal cells. In AMPS synthesis, the monosac-
charide units UDPGA and Gm-6-P are known
as important intermediates. UDPGA and
Gm-6-P can be formed by the activity of a
dehydrogenase and L-glut.-hexose-6-phosphate-
transamidase, respectively (3). It is also known
that the metabolism of AMPS is regulated
more or less by some hormones (4). In this
study, the three enzymes that synthesize
UDPGA and Gm-6-P, i.e. [JDPG-DH, L-glut.-
F6P-transamiclase and L-glut.-G6P-transami-
dase, were investigated after painting with a
carcinogenic hydrocarbon on mouse skin in-
fluenced by various hormones.
MATERIAL AND METHODS
Forty two female and twelve male Swiss albino
mice, weighing 16 to 23 g were kept on an optimum
laboratory diet, and were given water ad libulum.
They were divided into eight groups, i.e. normal,
DMBA and DMBA plus hormone-treated. Four
different hormones were tested. In the sex hor-
mone-treated groups, animals of both sexes were
used for any possible difference. The animals ex-
cept the normal controls received a single applica-
tion of 0.05 ml of 0.5% DMBA in benzene on the
shaved abdominal skin. The four different hor-
mones and doses used each time were as follows:
2.5% cortisone acetate suspension 0.1 ml (2.5 mg)
(Cortison-acetat Ciba©, Ciba), 1% DOCA suspen-
sion 0.1 ml (1.0 mg) (Percorten®, Ciba), 0.1%
Injectabile oestradioli benzoatis 0.1 ml (0.1 mg)
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'AMPS: acid mucopolysaccharides, UDPGA:
uridine diphosphoglucuronic acid, Gm-6-P: glu-
cosamine-6-phosphate, L-glut.: L-glutamine, hex-
ose-6-P: hexose-6-phosphate, UDPG-DH: uridine
diphosphoglucose dehydrogenase, DMBA: 9,10-
dimethyl-1 , 2-benzanthraeene, DOCA: desoxycor-
ticosterone acetate, FOP: fructose-6-phosphate,
GOP: glucose-6-phosphate, NAD: nicotinamide-
adenine dinucleotide.
(Ph. Nord. 63), and 5% Injectabile testosteroni
0.05 ml (2.5 mg) (Ph. Nord. 63). The hormones
were injected subcutaneously in the lateral femoral
region twice a week for four weeks. The DMBA-
treated animals were killed four weeks after paint-
ing, and the DMBA and hormone treated animals
three to six days after the last injection. The ab-
dominal skin was shaved, freed of subcutaneous
fatty tissue, and minced with a razor blade im-
mediately. The 20% tissue homogenate in 0.154
M KCI was made using a motor-driven glass
homogenizer at 4° C. The supernatant centrifuged
at 13,000 >< g for 60 minutes in a cooled Servall-
RC-2 centrifuge was used for the enzymatic assay.
The assay procedure for UDPG-DH of Strominger
et al (5) was used with a few modifications as
published previously by Sasaki (6). L-glut.-F6P-
transamidase and L-glut.-G6P-transamidase were
determined by the method of Pogell and Gryder
(7). Hexosamine and protein determinations were
carried out by the methods of Kirk and Dyrbye
(8) and Weichselbauni (9), respectively.
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RESULTS
Table I summarizes all the results.
The DMBA-treated skin showed higher
values than did the normals (P < 0.001). The
skin of DMBA plus cortisone, and DMBA
plus DOCA-treated mice showed lower activi-
ties than did the normals and the DMBA-
treated (P < 0.001). In the female DMBA
plus estradiol-treated, the UDPG-DH was
higher than in the normals (P < 0.001), while
no significant difference from that of the
DMBA-treated was found (P > 0.05). The
L-glut.-F6P-transamidase activity of the same
skin was lowest of all specimens, and the ac-
tivity of L-glut.-G6P-transamidase was higher
than in the normals (P < 0.001) and lower
than in the DMBA-treated (P < 0.001). In
the skin of DMBA plus estradiol-treated male
mice, the UDPG-DH activity was consider-
ably higher than both in the normals and the
DMBA-treated (P < 0.001). The L-glut.-F6P-
transamidase activity was higher than in the
normals (0.05 > P > 0.025), and lower than in
the DMBA-treated (P < 0.001). No L-glut.-
G6P-transamidase activity was observed.
In both sexes of DMBA plus testosterone-
treated mice, decreased activities of TJDPG-
DH and L-glut.-F6P-transamidase were oh-
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TABLE I
UDPG dehydrogenase, L-ytut.-F6P-transamidase and L-glut.-GCP-transamidase activities in the skin of
normal, DMBA and hormone-treated mice
Treatment IJDPG-DH
Normal 0.33 0.02 (12) 23.1 1.4 (13) 0.5 0.1 (15)
DMBA 0.40 0.03 (7) 35.5 1.4 (7) 3.4 0.3 (5)
DMBA + cortisone acetate 0.23 0.02 (5) 8.4 0.8 (5) 0 (5)
DMBA + DOCA 0.29 0.03 (5) 15.6 2.1 (5) 0 (5)
DMBA + estradiol benzoate
female 0.45 0.09 (5) 3.5 0.4 (5) 2.3 0.4 (5)
male 0.63 0.06 (5) 28.2 1.5 (6) 0 (6)
DMBA + testosterone propionate
female 0.24 0.02 (5) 5.0 0.6 (5) 0 (5)
male 0.25 + 0.03 (6) 7.1 (5) 1.7 0.1 (6)
Data for enzyme activities are in the following units: UDPG-DTT, jimoles of NAD reduced per minute
per mg protein, L-glut.-F6P-transamidasc and L-glut.-G6P-transamidase, pmoles of glucosamine syn-
thesized per hour per mg protein.
Each value represents the mean standard error of the mean.
The number of estimations are shown within parentheses.
served as compared with those of the normals
and the UMBA-treated (P < 0.001). The L-
glut.-G6P-transamidase activity of the same
skin in males was higher than in the normals
(P < 0.001), and lower than in the DMBA-
treated (P < 0.001), while nil in females.
DISCUS5ION
During the precancerous stages of cutaneous
tumor development induced in the mouse by
chemical means, a striking accumulation of
mast cells has been observed in the altered
dermis. This tissue reaction seems to occur
approximately 20 days after a single DMBA-
painting (10). Since active AMPS synthesis
was observed in the DMBA-trcatcd mice of
this study, it is reasonable to assume that in
the precancerous stages AMPS arc accumu-
lated in the skin, and also that AMPS ac-
cumulation occurs mostly in mast cells.
It is known that cortisone acts principally
on mesenchymal tissues and interferes with
the functions of mesenchymal cells, i.e. the
mast cells and the fib roblasts (4). Engclbreth-
Holm and Asboc-Hansen (11) reported that
an inhibition of the development of papillomas
and a reduction in the number of takes were
seen in mouse skin treated with DMBA and
cortisone. Evidence was supplied that cortisone
plays a role in inhibiting the accumulation of
ground substance AMPS in dermal connective
tissue. The results of this study indicate that
cortisone restricts AMPS synthesis in DMBA-
treated skin of mice. Some investigators found
evidence that DOCA stimulates the accumula-
tion of AMPS in the connective tissue, while
a few opposite reports arc available (12).
The previous results of Sasaki and Ketkar (13)
indicating a decrease in these enzyme activi-
ties in DOCA-trcated mouse skin, are con-
firmed by the above results and belong to the
latter group. Earlier reports on the effect of
estradiol benzoatc on AMPS metabolism and
synthesis are contradictory (14, 15). Previ-
ously (13), the author found UDPG-DH and
L-glut.-F6P-transamidasc increased in mouse
skin of both sexes after cstradiol benzoate
treatment. It was reported by Goldberg at al
(16) that large doses of estradiol benzoatc in-
hibits tumor growth. Considering that AMPS
is accumulated during skin carcinogencsis, the
demonstrated decrease of the value of L-glut.-
F6P-transamidase in female mouse skin might
support the above-mentioned report. A few
studies show that AMPS is accumulated in
normal skin after administration of testoster-
one (4). It was demonstrated by Sasaki and
Ketkar measuring IJDPG-DH and L-glut.-
F6P-transamidase activities that testosterone
has different effects on male and female mice
(13). However, in this study a definite de-
crease was seen in mouse skin after testosterone
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plus DMBA treatment in both sexes, although
the L-glut.-G6P-transamidase activity was
elevated in the male mice and although the
value was relatively low when compared with
L-glut.-F6P-transamidase activity. As the
AMPS synthesizing enzyme activities in the
skin of DMBA and testosterone-treated mice
were obviously lower than those in only
DMBA-treated mouse skin, it follows that
testosterone might have some inhibiting ac-
tion on skin carcinogenesis.
This assay was made on crude enzyme, and
the presence of traces of hcxose isomcrase can
not be excluded. Two different metabolic path-
ways may exist for the synthesis of Gm-6-P,
either from F6P or G6P. Pogcll and Gryder
(7) concluded that G6P, not F6P, was the ac-
tive substrate in the reaction with L-glut. on
the basis of relative activity studies and
stability experiments on a partially purified
enzyme of rat liver. G6P was also found to
be more active in excised granulation tissue
by Sasaki (6). Bollet and Shuster found both
G6P and F6P equally active in rat liver and
granulation tissue (17). However, these re-
sults arc in conflict with the report of Ghosh
et al (18) concluding that only F6P was re-
quired as a substrate among a few hexosc-6-P
in Escherichia coli, rat liver, and Neurospora
cromsa. In this study, F6P was found to be the
more stable substrate for the formation of
Gm-6-P.
SUMMARY
Three enzymes, IJDPG-DH, L-glut.-F6P-
transamidase, and L-glut .-G6P-transamidase,
which take part in AMPS synthesis were in-
vestigated in the skin of normal, DMBA-
treated, and DMBA plus various hormone-
treated mice. DMBA-treated skin showed
higher activities than did the normal. Low no-
tivities of the three enzymes were observed in
DMBA plus cortisone acetate, and DMBA
plus DOCA-treated mice, as compared with
those of the normals and those treated with
DMBA only. In the DMBA plus estradiol-
treated, the TJDPG-DH activity was higher
in both sexes than that of the normals, and
not significantly higher in females than that
of the DMBA-trcated, in contradistinction to
the male group. The same skin showed low
values of L-glut.-F6P-transamidasc activity in
females as compared with those of other speci-
mens, while in males it revealed higher activi-
ties than did the normals and lower than did
the DMBA-trcatcd. The L-glut.-G6P-trans-
amidase activity in females was found higher
than in the normals and lower than in the
DMBA-trcated, while nil in males. In the
DMBA plus testosterone-treated, the de-
creased activities of TJDPG-DH and L-glut.-
F6P-transamidasc were recognized in both
sexes as compared with those of the normals
and the DMBA-treated. In the L-glut.-G6P-
transamidase activity, the skin of male mice
showed higher values than did the normals
and lower than did the DMBA-trcatcd, while
no activity was seen in female mice.
REFERENCES
1. Prodi, G.: Acid mucopolysaccharides of the
dermis ground substance during skin treat-
ment with 9, 10-dimethyl-1 ,2-benzanthracene
and with croton oil. Brit. J. Cancer, 17: 504,
1963.
2. Dobson, H. L. and Griffin, M.: The histochem-
istry of cutaneous carcinogenesis. ,T. Invest.
Derm., 39: 597, 1962.
3. Roseman, S.: Mueopolysaccharide metabolism.
Am. J. Med., 26: 749, 1959.
4. Brunish, H.: p. 11, Hormones and Connective
Tissoe. Ed., Asboe-Hansen, G., Ejnar Munks-
gaard, Copenhagen, 1966.
5. Strominger, J. L., Maxwell, E. S., Axelrod, J.
and Kaickar, H. M.: Enzymatic formation
of uridine diphosphoglucuronic acid. J. Biol.
Chem., 224: 79, 1957.
6. Sasaki, S.: Enzymes leading to mucopolysae-
charide synthesis in granulation tissue. J.
Jap. Biochem. Soc., 37: 781, 1965.7. Pogell, B. M. and Gryder, R. M.: Enzymatic
synthesis of glucosamine 6-phosphate in rat
liver. J. Bid. Chem., 228: 701, 1957.
S. Kirk, J. E. and Dyrbye, M.: Hexosamine and
acid-hydrolysable sulfate concentrations of
the aorta and pulmonary artery in indi-
viduals of various ages. J. Gerontol., 11: 273,
1956.
9. Weichselbaum, T. E.: An accurate and rapid
method for the determination of proteins
in small amounts of blood serum and plasma.
Am. J. Chn. Path., Tech. Suppl., 16: 40,
1946.
10. Fiore-Donati, L., Dc Benedictis, G., Chieco-
Bianchi, L. and Bertacchini, G.: Develop-
ment of mast cell reaction during chemical
skin carcinogenesis of mouse. Nature, 193:
287, 1962.
11. Engelbreth-Hoim, J. and Asboe-Hansen, G.:
Effect of cortisone on skin carcinogenesis in
mice. Acta Path. & Microbiol. Scand., 32:
560, 1953.
12. Headings, V. E.: p. 124, Hormones and Con-
nective Tissue. Ed., Asboe-Hansen, G., Ejuar
Munksgaard, Copenhagen, 1966.
13. Sasaki, S. and Ketkar, M. B.: Effect of hor-
318 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
mones on acid mucopolysaccharide synthe-
sis in mouse skin. An enzyme study. Ex-
perientia, 1968.
14. Priest, R. E. and Koplitz, R. M.: Inhibition
of synthesis of sulfated mucopolysaceharides
by estradiol. J. Exp Med., .716: 565, 1962.15. Sinohara, H. and Sky-Peck, H. H.: The Ef-
fects of estradiol on acid mucopolysaccharide
metabolism in oophorectomized rats. Arch.
Biochem. Biophys., 106: 138, 1964.
16. Goldberg, M. P., Tregier, A. and Grossman,
M. S.: Mechanism of tumor inhibition by
estrogen. Proc. Soc. Exper. Biol. & Med.,
102: 408, 1959.
17. Bollet, A. J. and Shuster, A.: Metabolism of
mueopolysaecharides in connective tissue.
II. Synthesis of glucosamine-6-phosphate. J.
Olin. Invest., 39: 1114, 1960.
18. Ghosh, S., Blumenthal, H. J., Davidson, E.
and Roseman, S.: Glueosamine metabolism.
V. Enzymatic synthesis of glueosamine 6-
phosphate. J. Biol. Chem., 235: 1265, 1960.
